Clinical and genomic characterisation of early-onset pancreatic cancer

Cancer statistics, 2023

Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Estimated Projection of US Cancer Incidence and Death to 2040

Lola Rahib, Mackenzie R. Wehner, Lynn M. Matrisian et al. · JAMA Network Open · 2021 · 1.3K citations · Full text

Medicine, Health Policy, Oncology +17

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 787 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Akram Pourshams, Sadaf G Sepanlou, Kevin S Ikuta et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 672 citations · Full text

Medicine, Oncology, Preventive Medicine +17